Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [21] Enhanced Outcomes in Type 2 Diabetes Patients With Acute Kidney Disease Through Thiazolidinedione
    Chang, Li-Yang
    Liao, Hung-Wei
    Chen, Jui-Yi
    Wu, Vin-Cent
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [22] The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan
    Harada, Marina
    Kondo, Yoshinobu
    Sugiyama, Mai
    Ohira, Akeo
    Ichikawa, Masahiro
    Akiyama, Tomoaki
    Orime, Kazuki
    Takai, Takanori
    Yamakawa, Tadashi
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2022, : 121 - 128
  • [23] The METRO study: a retrospective analysis of the efficacy of metformin for type 2 diabetes in Japan
    Harada, Marina
    Kondo, Yoshinobu
    Sugiyama, Mai
    Ohira, Akeo
    Ichikawa, Masahiro
    Akiyama, Tomoaki
    Orime, Kazuki
    Takai, Takanori
    Yamakawa, Tadashi
    Terauchi, Yasuo
    ENDOCRINE JOURNAL, 2023, 70 (01) : 121 - 128
  • [24] Clinical efficacy of magnesium supplementation in patients with type 2 diabetes
    Yokota, K
    Kato, M
    Lister, F
    Li, H
    Hayakawa, T
    Kikuta, T
    Kageyama, S
    Tajima, N
    JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2004, 23 (05) : 506S - 509S
  • [25] Metformin: clinical use in type 2 diabetes
    Sanchez-Rangel, Elizabeth
    Inzucchi, Silvio E.
    DIABETOLOGIA, 2017, 60 (09) : 1586 - 1593
  • [26] The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
    Yau, Hanford
    Rivera, Kathya
    Lomonaco, Romina
    Cusi, Kenneth
    CURRENT DIABETES REPORTS, 2013, 13 (03) : 329 - 341
  • [27] The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
    Hanford Yau
    Kathya Rivera
    Romina Lomonaco
    Kenneth Cusi
    Current Diabetes Reports, 2013, 13 : 329 - 341
  • [28] Comparison of empagliflozin and vildagliptin for efficacy and safety in type 2 diabetes mellitus in the Pakistani population
    Khan, Asima
    Khan, Izhan A.
    Abidi, Hussain
    Ahmed, Mansoor
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [29] Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus
    Doucet, Jean
    Chacra, Antonio
    Maheux, Pierre
    Lu, Jane
    Harris, Susan
    Rosenstock, Julio
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (04) : 863 - 869
  • [30] Rivoglitazone: A New Thiazolidinedione for the Treatment of Type 2 Diabetes Mellitus
    Koffarnus, Robin L.
    Wargo, Kurt A.
    Phillippe, Haley M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) : 877 - 885
12345